Introduction
Increasing antimicrobial resistance of Streptococcus pyogenes has been observed during the last decade in Europe and worldwide. In 1992 Seppälä et al. 1 reported a high rate of erythromycin resistance (44%) in Finland, linked to an increased rate of erythromycin consumption in outpatients. High frequencies of erythromycin resistance have also been reported from Spain (17.1%), Italy (Ͼ40%) and the USA (32%). 2, 3 On the other hand, resistance rates as low as 0.5% and 1.6% have been found in The Netherlands 4 and in southwestern Germany, 5 respectively. This study was performed to determine the frequency of erythromycin resistance among S. pyogenes isolates in Berlin and to survey resistance to other antimicrobial agents. Previous studies have shown that erythromycin resistance might correlate with the patient's age; therefore, isolates from children and adult patients were examined in this study. Erythromycin-resistant strains were further analysed by a double-disc diffusion test with clindamycin and erythromycin to elucidate the underlying resistance mechanism.
Materials and methods

Bacteria
A total of 212 consecutive isolates of S. pyogenes were collected in Berlin from November 1996 to 1998. Of these, 159 isolates were obtained from adult patients (17-91 years) and 53 from children (8 months-16 years); 153 isolates were from pus samples and 59 from throat swabs. Identification was performed by routine laboratory techniques including latex agglutination (Streptex, Murex Biotech Ltd, Dartford, UK).
Determination of MICs
MICs of erythromycin (Sigma, Deisenhofen, Germany), clarithromycin (Abbot, Queensborough, UK), ciprofloxacin (Bayer, Leverkusen, Germany), penicillin (Grünen-thal, Aachen, Germany) and cefotaxime (Hoechst Marion Roussel, Frankfurt, Germany) were determined by an agar dilution method on Iso-Sensitest agar (Oxoid, Wesel, Germany) with 5% human blood. Inocula of 10 3 -10 4 cfu were applied by means of a multipoint inoculator and plates were incubated overnight at 37°C in an atmosphere of 5-7% CO 2 
Erythromycin and clindamycin double-disc diffusion test
This test was performed to classify the erythromycin resistance phenotype. 3 A disc containing 15 g erythromycin was placed 20 mm from the centre of a disc containing 10 g clindamycin on blood agar. Blunting of the clindamycin inhibition zone proximal to the erythromycin disc was taken to indicate an inducible resistance phenotype. Resistance to both erythromycin and clindamycin indicated constitutive resistance, and susceptibility to clindamycin with no blunting indicated the M-phenotype.
Results and discussion
Of the 212 S. pyogenes isolates, 27 (12.7%) were resistant to erythromycin, and one isolate (0.5%) showed intermediate susceptibility ( Table I ). The resistance rate was higher in isolates from children (18.9%) than in those from adults (10.7%). Although the difference was not statistically significant (P ϭ 0.16, chi-squared test), these results suggest that children might be more likely to be infected with erythromycin-resistant strains. Erythromycin resistance was 10% among invasive strains (n ϭ 10) isolated from blood cultures and CSF, and 12.9% among non-invasive strains (n ϭ 202). Our data are in accordance with the results of Fierek et al., 9 who found an erythromycin resistance rate of 10% among a collection (number not specified) of S. pyogenes isolates from respiratory tract infections during 1995-1996 in Greifswald, north-eastern Germany. On the other hand, in 1997 Traub & Leonhard 5 reported an erythromycin resistance rate of 1.6% among 63 S. pyogenes isolates in Homburg/Saar, south-western Germany. This discrepancy might be due to differences in the time point of collecting the isolates, the site of infection or the age group of the patients studied, since these parameters were not specified in the latter study. However, the frequency of erythromycin resistance in S. pyogenes might also vary considerably between different geographical regions of Germany.
All erythromycin-resistant strains were also resistant to clarithromycin and vice versa. We did not find any significant differences between clarithromycin and erythromycin with respect to MIC range, MIC 50 and MIC 90 . All strains were susceptible to penicillin and cefotaxime (Table II) , confirming that penicillin resistance has not developed in S. pyogenes.
The MIC 50 and MIC 90 of ciprofloxacin were 0.5 and 1 mg/L, respectively. Six isolates revealed an MIC value of 4 mg/L. NCCLS 7 has not defined MIC breakpoints of ciprofloxacin for S. pyogenes. According to the DIN guidelines, 8 the resistant and susceptible breakpoints for ciprofloxacin are у4 mg/L and р1 mg/L, respectively, although these breakpoints have not been specifically defined for S. pyogenes. Applying these DIN breakpoints, the ciprofloxacin resistance rate was 2.8% (Table II) . Clindamycin resistance was not detected among the erythromycin-susceptible strains by agar diffusion. However, of the 20 erythromycin-resistant strains subjected to the double-disc diffusion test for erythromycin and clindamycin, seven (35%) expressed constitutive resistance to clindamycin. Eleven strains (55%) showed resistance to clindamycin only when exposed to the double-disc diffusion test, suggesting an inducible resistance phenotype. Thus, 90% of the erythromycin-resistant isolates also expressed resistance to clindamycin, indicating a macrolide, lincosamide and streptogramin B (MLS B ) resistance phenotype caused by conformational changes in the prokaryotic ribosome.
10 Two (10%) strains were susceptible to clindamycin even when exposed to the double-disc diffusion test, indicating the M-phenotype, which is probably caused by a drug efflux mechanism. 10 In Finland, the proportion of M-phenotype among erythromycin-resistant strains has increased from 40% in 1990 to 80% in 1994, indicating a clonal spread of this phenotype. 10 Our data indicate that in Berlin the prevalence of this phenotype is rather low.
In conclusion, this study demonstrates a high rate of erythromycin resistance in S. pyogenes in the Berlin area of Germany and emphasizes the need to screen for antimicrobial resistance among S. pyogenes.
